Clincosm LogoSign in Get a demo

cutaneous squamous cell carcinoma

Showing 1 - 25 of 57
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Tumor, Solid, Malignant Tumor Trial (OR502, Cemiplimab)

Not yet recruiting
  • Cancer
  • +6 more
  • (no location specified)
Oct 16, 2023

Needs and Preferences of Patients With Head-neck Cutaneous SCC

Active, not recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +10 more
  • Regular care with additional administration of a semi-structured interview
  • Maastricht, Netherlands
    Maastricht University Medical Center+
Sep 13, 2023

Solid Tumor, Cutaneous Squamous Cell Carcinoma, Endometrial Cancer Trial (favezelimab/pembrolizumab, pembrolizumab, lenvatinib)

Not yet recruiting
  • Solid Tumor
  • +2 more
  • favezelimab/pembrolizumab
  • +2 more
  • (no location specified)
Sep 7, 2023

Interobserver Variability Desmoplasia

Active, not recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +3 more
  • Assessment by dermatopathologists
  • Maastricht, Netherlands
    Maastricht University Medical Center+
Aug 29, 2023

Complications and Recurrences After Mohs Micrographic Surgery

Recruiting
  • Skin Cancer
  • +9 more
  • Mohs surgery
  • Slow Mohs surgery
  • Maastricht, Netherlands
    Maastricht University Medical Center+
Aug 23, 2023

OCT and Invasion in Cutaneous Skin Lesions

Active, not recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +4 more
  • Optical Coherence Tomography
  • Clinical assessment
  • Maastricht, Netherlands
    Maastricht University Medical Center+
Aug 23, 2023

Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma Trial in Orlando (Exercise Test)

Not yet recruiting
  • Cutaneous Melanoma
  • +2 more
  • Exercise Test
  • Orlando, Florida
    AdventHealth Translational Research Institute
Aug 18, 2023

Cutaneous Squamous Cell Carcinoma Trial (INCB099280)

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • (no location specified)
May 24, 2023

Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Tumors Trial in Melbourne

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +3 more
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
May 17, 2023

Cutaneous Squamous Cell Carcinoma, SCC - Squamous Cell Carcinoma, Basal Cell Carcinoma Trial in United States (MQ719,

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +18 more
  • Basking Ridge, New Jersey
  • +6 more
May 18, 2023

Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma Trial

Not yet recruiting
  • Basal Cell Carcinoma
  • Cutaneous Squamous Cell Carcinoma
    • (no location specified)
    Feb 14, 2023

    Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma Trial in Miami (Cemiplimab-Rwlc,

    Not yet recruiting
    • Cutaneous Squamous Cell Carcinoma
    • +2 more
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc.
    Feb 6, 2023

    Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma Trial in Lausanne (FLASH RT, Conventional RT)

    Not yet recruiting
    • Basal Cell Carcinoma
    • Cutaneous Squamous Cell Carcinoma
    • FLASH RT
    • Conventional RT
    • Lausanne, Vaud, Switzerland
      Centre Hospitalier Universitaire Vaudois (CHUV)
    Feb 13, 2023

    Cutaneous Squamous Cell Carcinoma Staging Study

    Not yet recruiting
    • Cutaneous Squamous Cell Carcinoma
    • This is not an interventional study
    • (no location specified)
    Jan 20, 2023

    Cutaneous Squamous Cell Carcinoma, Advanced Cancer Trial in Boston (Cemiplimab, Everolimus, Sirolimus)

    Recruiting
    • Cutaneous Squamous Cell Carcinoma
    • Advanced Cancer
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 19, 2023

    Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer Trial in United States

    Recruiting
    • Non Small Cell Lung Cancer
    • +11 more
    • Denver, Colorado
    • +3 more
    Jan 10, 2023

    Cutaneous Squamous Cell Carcinoma Trial in Tampa (Pramlintide)

    Suspended
    • Cutaneous Squamous Cell Carcinoma
    • Tampa, Florida
      Moffitt Cancer Center
    Dec 30, 2022

    Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)

    Active, not recruiting
    • Advanced Cancer
    • +16 more
    • Scottsdale, Arizona
    • +3 more
    Dec 22, 2022

    CemiplimAb Survivorship Epidemiology

    Recruiting
    • Cutaneous Squamous Cell Carcinoma
    • Basal Cell Carcinoma
    • Huntsville, Alabama
    • +52 more
    Dec 14, 2022

    Cutaneous Squamous Cell Carcinoma Trial in Worldwide (Cemiplimab, Placebo)

    Recruiting
    • Cutaneous Squamous Cell Carcinoma
    • Gilbert, Arizona
    • +143 more
    Dec 1, 2022

    Advanced Solid Tumor, MSI-H/dMMR Tumors, Cutaneous Squamous Cell Carcinoma Trial in Worldwide (INCB099280)

    Recruiting
    • Advanced Solid Tumor
    • +11 more
    • Boston, Massachusetts
    • +30 more
    Dec 1, 2022

    Cutaneous Squamous Cell Carcinoma, Skin Cancers - Squamous Cell Carcinoma Trial in Pittsburgh (Microneedle Array Doxorubicin

    Not yet recruiting
    • Cutaneous Squamous Cell Carcinoma
    • Skin Cancers - Squamous Cell Carcinoma
    • Microneedle Array Doxorubicin (MNA-D)
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Medical Center
    Nov 28, 2022

    Squamous Cell Carcinoma, Nonmelanoma Skin Cancer, Cutaneous Squamous Cell Carcinoma Trial in Indianapolis (sentinel lymph node

    Recruiting
    • Squamous Cell Carcinoma
    • +2 more
    • sentinel lymph node biopsy (SLNB)
    • Indianapolis, Indiana
      Indiana University Melvin & Bren Simon Cancer Center
    Nov 15, 2022

    Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck Trial in Tucson, Tampa

    Terminated
    Has Results
    • Cutaneous Squamous Cell Carcinoma
    • Cutaneous Squamous Cell Carcinoma of the Head and Neck
    • Tucson, Arizona
    • +1 more
    Nov 2, 2022

    Advanced Solid Tumor, Unresectable Solid Tumor, Melanoma Trial in Australia, Canada, United States (MDNA11 Monotherapy, MDNA11

    Recruiting
    • Advanced Solid Tumor
    • +24 more
    • MDNA11 Monotherapy
    • MDNA11 in combination with checkpoint inhibitor
    • Santa Monica, California
    • +7 more
    Nov 1, 2022